Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 697617, 9 pages
http://dx.doi.org/10.1155/2014/697617
Clinical Study

A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial

1Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, P.O. Box 81465-1148, Iran
2Isfahan Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, P.O. Box 81465-1148, Iran

Received 13 April 2014; Accepted 16 June 2014; Published 25 August 2014

Academic Editor: Anderson O. Wong

Copyright © 2014 Hamidreza Roohafza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hamidreza Roohafza, Pedram Shokouh, Masoumeh Sadeghi, Zahra Alikhassy, and Nizal Sarrafzadegan, “A Possible Role for Pioglitazone in the Management of Depressive Symptoms in Metabolic Syndrome Patients (EPICAMP Study): A Double Blind, Randomized Clinical Trial,” International Scholarly Research Notices, vol. 2014, Article ID 697617, 9 pages, 2014. doi:10.1155/2014/697617